Drug intelligence / Profile preview

Juvéderm VYCROSS

Development stage
Unknown
Lead developer
Allergan Aesthetics
Administration
Intradermal, Subcutaneous
01

Overview

Juvéderm VYCROSS is a proprietary cross-linking technology developed by Allergan Aesthetics (an AbbVie company) for its collection of hyaluronic acid (HA) dermal fillers. The technology combines 90% low molecular weight HA with 10% high molecular weight HA to create a smoothly integrated, long-lasting gel that provides structural support and hydration to facial tissues. Most products in the VYCROSS collection also contain 0.3% lidocaine to minimize discomfort during the injection process. The collection includes specialized formulations such as Voluma for cheek and chin volume, Volbella for lip augmentation and fine lines, and Volux for jawline definition. These products function as injectable implants that add volume to tissue and help retain moisture, with results typically lasting between 6 to 24 months depending on the specific product and treatment area.

Brand names
Juvéderm VYCROSSJUVÉDERM VOLUMAJUVÉDERM VOLLUREJUVÉDERM VOLBELLAJUVÉDERM VOLIFTJUVÉDERM VOLITEJUVÉDERM VOLUX
Other names
VYCROSS technologycross-linked hyaluronic acid
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on Juvéderm VYCROSS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Juvéderm VYCROSS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call